<DOC>
	<DOCNO>NCT00169572</DOCNO>
	<brief_summary>This study design assess safety efficacy investigational agent administer addition standard anti-emetic regimen treatment chemotherapy induce nausea vomiting .</brief_summary>
	<brief_title>Study The Prevention Of Nausea Cancer Patients Receiving Highly Emetogenic Cisplatin Based Chemotherapy</brief_title>
	<detailed_description>Phase II Multicentre , Randomised , Double-Blind , Placebo Active-Controlled , Dose-Ranging , Parallel Group Study Safety Efficacy The Oral Neurokinin-1 Receptor Antagonist , GW679769 Combination Ondansetron Hydrochloride Dexamethasone Prevention Chemotherapy-Induced Nausea Vomiting Cancer Subjects Receiving Highly Emetogenic Cisplatin-based Chemotherapy .</detailed_description>
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Aprepitant</mesh_term>
	<mesh_term>Fosaprepitant</mesh_term>
	<mesh_term>Casopitant</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<criteria>Inclusion criterion : Willing provide write informed consent prior receive studyspecific procedure assessment . Diagnosed solid malignant tumour previously receive chemotherapy . Scheduled receive chemotherapy conducive regimen outline study protocol . Exclusion criterion : Not receive investigational product within 30 day enrolment study . Must pregnant . Must childbearing potential willing use specific barrier method outline protocol . Must schedule receive radiation therapy abdomen pelvis within seven ( 7 ) day prior start study medication . Must currently treatment condition may cause nausea vomit ( i.e. , active peptic ulcer disease , gastric obstruction ) . Must history peptic ulcer disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Nausea</keyword>
	<keyword>Vomiting</keyword>
	<keyword>Emesis</keyword>
	<keyword>Chemotherapy-induced Nausea Vomiting</keyword>
	<keyword>CINV</keyword>
</DOC>